Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: BG Medicine, Danaher, Provista

Premium

BG Medicine has tapped Paul Sohmer to be president, CEO, and a member of its board of directors, effective immediately, the company said this week. He replaces Eric Bouvier, who will remain with the company as a consultant.

Sohmer previously was CEO of several medical device and diagnostics companies, including Pathway Diagnostics, Viracor-IBT Laboratories, and Orthocon, and he was chairman, president, and CEO of TriPath Imaging before it was acquired by Becton Dickinson.

Early in his career, Sohmer also was CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.


Danaher has re-elected seven directors to continue serving on the board until their terms expire in 2014, including Steven Rales, Donald Ehrlich, Linda Hefner Filler, Teri List-Stoll, Walter Lohr, John Schwieters, and Alan Spoon.


Provista Diagnsotics' stockholders have re-elected the members of its board of directors, including Anne Busquet, Jeffrey Gilman, Robert Hariri, Jack Levine, John Macaskill, David Reese, and John Zicarelli.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.